Drug resistance
This article was originally published in The Tan Sheet
Executive Summary
FDA is sponsoring a Nov. 9-10 public hearing on how best to implement a surveillance system to track bacterial resistance to human and animal antimicrobial agents. FDA's Anti-Infective Drugs and Veterinary Medicine Advisory Committees have previously recommended improved surveillance through a cooperative effort involving government, academia and industry. The hearing will take place at the Rockville Civic Center, 603 Edmonston Drive, in Rockville, Md. beginning at 8:30 a.m. each day. For further information, call 301/309-3007
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning